Patient Offices
- Address
-
5 East 98th Street, 7th Floor
New York, NY 10029
- Tel
- 212-241-9638
- Fax
- 212-831-3324
- Office Hours
- Monday 9:00 AM - 5:00 PM
- Tuesday 9:00 AM - 5:00 PM
- Wednesday 9:00 AM - 5:00 PM
- Thursday 9:00 AM - 5:00 PM
- Friday 9:00 AM - 5:00 PM
- Disabled Access
- Yes
Insurance Plans Accepted
Disclaimer - Please note that the insurance accepted list may not be complete. Prior to scheduling an appointment, please contact the doctors' office to verify their participation in your plan.
- Address
-
1190 Fifth Avenue
New York, NY 10029
- Tel
- 212-241-9638
- Fax
- 212-831-3324
- Disabled Access
- No
Business Offices
- Address
-
Annenberg Building Floor 8th Room 86
1468 Madison Avenue
New York, NY 10029
- Tel
- 212-241-9638
- Fax
- 212-831-3324
Isabelle M. Germano
PROFESSOR Neurosurgery
PROFESSOR Neurology
PROFESSOR Oncological Sciences
Overview
| Specialty |
Neurological Surgery
|
| Clinical Interests |
Brain Cancer |
| |
Brain Tumors |
| |
Brain Mestasis |
| |
Minimally Invasive Brain Surgery |
| |
Meningioma |
| |
Radiosurgery |
| |
Epilepsy Surgery |
| |
Brain Mapping |
| |
Movement Disorders |
| |
Spine Surgery |
| Languages |
English |
| |
French |
| |
German |
| |
Spanish |
| |
Italian |
| Gender |
Female |
| E-mail |
isabelle.germano@mountsinai.org |
| Education and Training |
MD, University of Turin Medical School |
| |
Residency, Neurosurgery, Albert Einstein College of Medicine |
| |
Residency, Neurosurgery, Univ. of California, San Francisco |
| |
Residency, Surgery, Univ. of California, San Francisco |
| |
Fellowship, Neurosurgery, University of Zurich |
| |
Fellowship, Neurosurgery, Montreal Neurological Institute |
| Awards |
2008 - 2012 Research grant: Brain tumors and gene transfer National Institute of Health |
| |
2007 Brain Tumor Research Goldhirsh Foundation |
| |
2006 New York State Certificats of Recognition, Dedication and Service to the Italians Culture and Community New York State |
| |
2006 Life Time Member Who is Who Strathmore's |
| |
2005 Certificate of Excellence in Youth Education New York City Department of Education and Mount Sinai School of Medicine |
| |
2004 Neurosurgery Research Award New York State Society |
| |
2002 - 2006 America's Top Cancer Doctors Castle Connolly |
| |
2000 - 2006 Top Doctors New York Metro Area Castle Connolly |
| |
2000 - 2006 America's Top Doctors 1-5th edition Castle Connolly |
| |
2000 - 2006 Best Doctors Of New York New York Magazine |
Dr. Germano joined the faculty at Mount Sinai in 1993. Her specialty interests include Brain Tumors, Computer-Assisted Image-Guided Neurosurgery, Parkinson's disease and Movement Disorders, Epilepsy and Radiosurgery. She is Director of The Mount Sinai Medical Center Stereotactic and Brain Tumor Program, an advanced multidisciplinary program based on computer-assisted image-guided neurosurgery and brain mapping to accomplish minimally invasive procedures and treatment of brain tumors. Dr. Germano is one of the pioneers of computer-assisted image-guided neurosurgery. This sophisticated technology, including the Novalis Shaped Beam Surgery, is used to perform minimally invasive surgery for patients with brain tumors, epilepsy, Parkinson's disease and movement disorders. Active in national neurosurgery organizations, she has served as an executive committee member for the Congress of Neurosurgery (CNS), as a Board of Directors' member for the American Association of Neurological Surgeons, as an executive committee member of the AANS/CNS Joint Section on Tumors, and as a scientific program member for the AANS, CNS, and the American Epilepsy Society. For the past five years she has directed a course, Advanced Techniques in Image-Guided Brain and Spine Surgery, for neurosurgeons from around the country. In the NewsDr. Germano and her work diagnosing and treating brain tumors were recently profiled in The Daily News feature The Daily Check Up. View the PDF.
Training
| Education and Training |
MD, University of Turin Medical School |
| |
Residency, Neurosurgery, Albert Einstein College of Medicine |
| |
Residency, Neurosurgery, Univ. of California, San Francisco |
| |
Residency, Surgery, Univ. of California, San Francisco |
| |
Fellowship, Neurosurgery, University of Zurich |
| |
Fellowship, Neurosurgery, Montreal Neurological Institute |
| Board Certification |
Neurological Surgery |
Clinical Practice
| Specialty |
Neurological Surgery
|
| Clinical Interests |
Brain Cancer |
| |
Brain Tumors |
| |
Brain Mestasis |
| |
Minimally Invasive Brain Surgery |
| |
Meningioma |
| |
Radiosurgery |
| |
Epilepsy Surgery |
| |
Brain Mapping |
| |
Movement Disorders |
| |
Spine Surgery |
| Languages |
English |
| |
French |
| |
German |
| |
Spanish |
| |
Italian |
| Board Certification |
Neurological Surgery |
Research
Translational research for malignant brain tumors The main focus of the laboratory is to investigate new strategies for adjuvant treatment of malignant brain tumors. With the support from the National Institutes of Health, NIH, private foundations and Industry, the laboratory has been very productive in investigating new promising modalities and compound to kill brain tumor cells. Embryonic stem cells are currently used in animal models to transfer genes to brain tumors.
Image-guide computer-assisted neurosurgery One of the pioneers in this field, Dr. Germano continues to collaborate with the industry in making neurosurgical resections more accurate and less invasive.
Related Link: Brain Tumor and Gene Therapy Laboratory
Publications
Uzzaman M, Keller G, Germano I. In vivo Gene Delivery by embryonic stem cell-derived astrocytes for malignant gliomas. Neuro-Oncology 2008;.
Benzil D, Abosch A, Germano IM, Gilmer H, Maraire N, Muraszko K, Pannullo S, Rosseau G, Schwartz L, Todor R, Ullman J, Zusman E. The future of neurosurgery: a white paper on the recruitment and retention of women in neurosurgery. J Neurosurgery 2008; 109: 367-375.
Germano IM, Uzzaman M, Keller G. Gene delivery by embryonic stem cells for malignant gliomas. Cancer Biology and Therapy 2008; 7: 81-87.
Uzzaman M, Keller G, Germano IM. Enhanced pro-apotptotic effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) on temozolomide-resistant glioma cells. J Neurosurgery 2007; 106: 646-651.
Germano I, Uzzaman M, Benveniste R, Zaurova M, Keller G. Apoptosis in human glioma cells produced using embryonic stem cell-derived astrocytes expressing tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Neurosurgery 2006; 105: 88-95.
Uzzaman M, Benveniste R, Keller G, Germano IM. Embryonic stem cell-derived astrocytes: novel gene therapy vector for brain tumors. Neurosurgical Focus 2005; 19(3): E6.
Benveniste R, Keller G, Germano IM. Embryonic stem cell-derived astrocytes expressing drug-inducible transgenes: Differentiation and allotransplantation into the mouse brain. J Neurosurgery 2005; 103: 115-123.
Benveniste R, Germano IM. Correlation of factors predicting intraoperative brain shift with successful resection of malignant brain tumors using image-guided techniques. Surg Neurol 2005; 63: 542-549.
Kanzawa T, Zhang L, Xiao L, Germano IM, Kondo Y, Kondo S. Arsenic trioxide induces autophagic cell death in malignant glioma cells by up-regulation of mitochondrial cell death protein BNIP3. Oncogene 2005; 24: 980-991.
Germano IM, Gracies JM, Weisz DJ, Tse W, Koller WC, Olanow CW. Unilateral stimulation of the subthalamic nucleus in Parkinson's disease- a double blind 12-month evaluation study. J Neurosurgery 2004; 101: 36-42.
|
View All Service Areas
Discover how The Mount Sinai Medical Center can offer you the most advanced and compassionate inpatient and outpatient care.
Institutes, Centers, Programs and Laboratories
The Mount Sinai Medical Center is home to an extensive array of top-notch research centers and laboratories, where scientists and researchers work to translate the rapid advances in basic science into the innovative patient care for which we are known.
Clinical Trials
Participating in Mount Sinai’s clinical trials allows you to take advantage of innovative treatments as we work together to advance the future of medicine.
|